AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SCIENCE IN SPORT PLC

Capital/Financing Update Jan 16, 2018

7904_rns_2018-01-16_be2e421e-003f-4479-8bcc-d6acf8f98ac1.html

Capital/Financing Update

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9315B

Science in Sport PLC

16 January 2018

For immediate release 16 January 2018

SCIENCE IN SPORT PLC

("SiS" or the "Company")

Pre-Close Trading Update

Science in Sport plc (AIM: SIS), a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts, is pleased to announce the following pre-close trading update for the 12 months ended 31 December 2017. The Group traded well in 2017 and expects to report a full year result in line with expectations.

Sales increased 28% to £15.6 million in the 12 months to 31 December 2017 compared with the same period the previous year (2016: £12.2 million).

Continued investment in the Company's scienceinsport.com platform and operations resulted in a 58% increase in direct sales year on year to £4.6m. Third-party Online retailers delivered robust growth of 27% to £3.9m. Retail sales including distributors outgrew the market at 13.8% to £7.1m.

Further development of International markets was a key focus during the year. Growth across all International revenue was 60% reaching £4.4m. Ex-plan investment was made in the USA and Italy which has set these markets up for significant growth in 2018 following the raising of additional funding in December 2017.  The Australian business continued to perform to expectation.

Marketing investment resulted in record levels of brand awareness and usage.

The Board remains confident of continued strong growth in 2018 and beyond. The Company intends to issue its full year results on Wednesday 21 March 2018.

For further information:

Science in Sport plc www.scienceinsport.com
Science in Sport PLC
Stephen Moon, CEO

Elizabeth Lake, Finance Director
+44 (0) 20 7400 3700
Cenkos Securities +44 (0) 20 7397 8900
Bobbie Hilliam - NOMAD and Broker

Notes for editors

About Science in Sport plc

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community - in the 2016 Rio Olympics, 34 medal-winning athletes or teams used SiS products (compared with 24 in 2012).

The SiS core product ranges include: SiS GO, comprising energy powders, isotonic gels, energy bars and hydration tablets; SiS REGO, including protein-based recovery powders and bars; SiS Protein, products specifically designed to contribute to athletes' lean muscle mass growth and maintenance; SiS supplements, comprising BCAA Perform, Creatine, Beta Alanine, L Glutamine and SiS Immune. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites.

SiS is currently the official sports nutrition supplier to professional cycling teams Team SKY along with national associations British Cycling, Cycling Australia, USA Cycling, USA Triathlon and British Triathlon. In addition, Olympians Sir Chris Hoy MBE, and Mark Cavendish MBE are Brand Ambassadors.

SiS was founded in 1992 and is headquartered in Hatton Garden, London. Its manufacturing facility is in Nelson, Lancashire.

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTLLFERLIIELIT

Talk to a Data Expert

Have a question? We'll get back to you promptly.